{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T01:37:04Z","timestamp":1781055424203,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2016YFC1305104"],"award-info":[{"award-number":["2016YFC1305104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation for Exploration Project of Shanghai","award":["19ZR1478200"],"award-info":[{"award-number":["19ZR1478200"]}]},{"name":"Natural Science Foundation for Exploration Project of Shanghai","award":["2019"],"award-info":[{"award-number":["2019"]}]},{"name":"The Military Medical Science and Technology Project","award":["21QNY041"],"award-info":[{"award-number":["21QNY041"]}]},{"name":"The Military Medical Science and Technology Project","award":["2021"],"award-info":[{"award-number":["2021"]}]},{"name":"The 'Deep Blue 123' Military Medical Research Project","award":["2020SLZ007"],"award-info":[{"award-number":["2020SLZ007"]}]},{"name":"The 'Deep Blue 123' Military Medical Research Project","award":["2020"],"award-info":[{"award-number":["2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Islet transplantation is used therapeutically in a minority of patients with type 1 diabetes (T1D). However, successful outcomes are hampered by early islet \u03b2-cell loss caused by immune rejection and autoimmunity. Recent studies have demonstrated that mesenchymal stromal cells can enhance islet function both in vitro and in vivo by secreting ligands that activate islet G-protein coupled receptors (GPCRs). Stromal cell-derived factor 1 (SDF-1) is an MSC-secreted GPCR ligand, whereas the suppressor of cytokine signaling 3 (SOCS3) is a negative regulator of STAT3-activating cytokines. Here, we determined whether improvement in islet function mediated by exogenous SDF-1 is impaired by SOCS3 in experimental models of T1D.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Isolated islets were cultured for 48\u00a0h with SDF-1. Cytokine-induced apoptosis was measured immediately. Islets from <jats:italic>Socs3<\/jats:italic><jats:sup>\u2212\/\u2212<\/jats:sup> mice were pre-cultured with exogenous SDF-1 and transplanted underneath the kidney capsule of C57BL\/6 mice with streptozotocin-induced diabetes. Blood glucose levels were monitored for 28\u00a0days. AMD3100, an antagonist of the SDF-1 ligand CXCR4, was administered subcutaneously to islet transplanted mice to inhibit CXCR4 before and after transplantation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>SDF-1 protected islet cells from cytokine-induced apoptosis in vitro. SOCS3-knockout (KO) islets pretreated with SDF-1 were effective in reducing blood glucose in non-obese diabetic mice in vivo. We found that SDF-1 elicits localized immunosuppression in transplanted SOCS3-KO islets. Immunomodulation was observed when SOCS-KO islets were preconditioned with SDF-1. Gene expression and flow cytometric analyses revealed significantly decreased immune cell infiltration, inflammatory cytokines, and concomitant increases in FOXP3<jats:sup>+<\/jats:sup> regulatory T cells, alternatively activated M2 macrophages, and dendritic cell phenotypes. Administration of AMD3100 impaired the SDF-1-mediated improvement in SOCS3-KO islet function and local immune suppression.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SDF-1 improves the function of islet grafts in autoimmune diabetes through regulation by CXCR4; however, the presence of SOCS3 reverses the protective effect of SDF-1 on islet grafts. These data reveal a molecular pathway that can elicit localized immunosuppression and delay graft destruction in transplanted islets.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-023-03347-y","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T13:03:00Z","timestamp":1688389380000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["SOCS3 inhibits the mesenchymal stromal cell secretory factor SDF-1-mediated improvement of islet function in non-obese diabetic mice"],"prefix":"10.1186","volume":"14","author":[{"given":"Mingxing","family":"Sui","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanlan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7981-794X","authenticated-orcid":false,"given":"Li","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"3347_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/ijms21010036","volume":"21","author":"M Cerna","year":"2020","unstructured":"Cerna M. Epigenetic regulation in etiology of type 1 diabetes mellitus. Int J Mol Sci. 2020;21:36.","journal-title":"Int J Mol Sci"},{"key":"3347_CR2","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.2147\/DMSO.S275080","volume":"13","author":"S Butalia","year":"2020","unstructured":"Butalia S, Kaplan GG, Khokhar B, Haubrich S, Rabi DM. The challenges of identifying environmental determinants of type 1 diabetes: in search of the holy grail. Diabetes Metab Syndr Obes Targets Ther. 2020;13:4885\u201395.","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"3347_CR3","doi-asserted-by":"publisher","first-page":"e201900350","DOI":"10.26508\/lsa.201900350","volume":"2","author":"CM Lee","year":"2019","unstructured":"Lee CM, He CH, Park JW, Lee JH, Kamle S, Ma B, et al. Chitinase 1 regulates pulmonary fibrosis by modulating TGF-\u03b2\/SMAD7 pathway via TGFBRAP1 and FOXO3. Life Sci Alliance. 2019;2:e201900350.","journal-title":"Life Sci Alliance"},{"key":"3347_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/MED.0000000000000551","volume":"27","author":"S Tell","year":"2020","unstructured":"Tell S, Nadeau KJ, Eckel RH. Lipid management for cardiovascular risk reduction in type 1 diabetes. Curr Opin Endocrinol Diabetes Obes. 2020;27:207\u201314.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"3347_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.35772\/ghm.2020.01057","volume":"2","author":"T Takaki","year":"2020","unstructured":"Takaki T, Shimoda M. Pancreatic islet transplantation: toward definitive treatment for diabetes mellitus. Glob Health Med. 2020;2:200\u201311.","journal-title":"Glob Health Med"},{"key":"3347_CR6","doi-asserted-by":"publisher","first-page":"2424586","DOI":"10.1155\/2018\/2424586","volume":"2018","author":"X Li","year":"2018","unstructured":"Li X, Meng Q, Zhang L. The fate of allogeneic pancreatic islets following intraportal transplantation: challenges and solutions. J Immunol Res. 2018;2018:2424586.","journal-title":"J Immunol Res"},{"key":"3347_CR7","doi-asserted-by":"publisher","first-page":"451035","DOI":"10.1155\/2014\/451035","volume":"2014","author":"MA Kanak","year":"2014","unstructured":"Kanak MA, Takita M, Kunnathodi F, Lawrence MC, Levy MF, Naziruddin B. Inflammatory response in islet transplantation. Int J Endocrinol. 2014;2014:451035.","journal-title":"Int J Endocrinol"},{"key":"3347_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.beem.2018.02.005","volume":"32","author":"G Sebastiani","year":"2018","unstructured":"Sebastiani G, Ceccarelli E, Castagna MG, Dotta F. G-protein-coupled receptors (GPCRs) in the treatment of diabetes: current view and future perspectives. Best Pract Res Clin Endocrinol Metab. 2018;32:201\u201313.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3347_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/sctm.18-0033","volume":"7","author":"AA Arzouni","year":"2018","unstructured":"Arzouni AA, Vargas-Seymour A, Nardi N, J.F. King A, Jones PM. Using mesenchymal stromal cells in islet transplantation. Stem Cells Transl Med. 2018;7:559\u201363.","journal-title":"Stem Cells Transl Med"},{"key":"3347_CR10","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00125-009-1374-z","volume":"52","author":"AM Madec","year":"2009","unstructured":"Madec AM, Mallone R, Afonso G, Abou Mrad E, Mesnier A, Eljaafari A, et al. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia. 2009;52:1391\u20139.","journal-title":"Diabetologia"},{"key":"3347_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.4049\/jimmunol.0900803","volume":"183","author":"P Fiorina","year":"2009","unstructured":"Fiorina P, Jurewicz M, Augello A, Vergani A, Dada S, La Rosa S, et al. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol. 2009;183:993\u20131004.","journal-title":"J Immunol"},{"key":"3347_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.coph.2018.07.011","volume":"43","author":"CL Rackham","year":"2018","unstructured":"Rackham CL, Jones PM. Potential of mesenchymal stromal cells for improving islet transplantation outcomes. Curr Opin Pharmacol. 2018;43:34\u20139.","journal-title":"Curr Opin Pharmacol"},{"key":"3347_CR13","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.jcyt.2018.07.007","volume":"20","author":"CL Rackham","year":"2018","unstructured":"Rackham CL, Amisten S, Persaud SJ, King AJF, Jones PM. Mesenchymal stromal cell secretory factors induce sustained improvements in islet function pre- and post-transplantation. Cytotherapy. 2018;20:1427\u201336.","journal-title":"Cytotherapy"},{"key":"3347_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pharmthera.2018.08.011","volume":"193","author":"DA Alagpulinsa","year":"2019","unstructured":"Alagpulinsa DA, Cao JJL, Sobell D, Poznansky MC. Harnessing CXCL12 signaling to protect and preserve functional \u03b2-cell mass and for cell replacement in type 1 diabetes. Pharmacol Ther. 2019;193:63\u201374.","journal-title":"Pharmacol Ther"},{"key":"3347_CR15","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2174\/1574888X11666160614102629","volume":"11","author":"Q Luo","year":"2016","unstructured":"Luo Q, Zhang B, Kuang D, Song G. Role of stromal-derived factor-1 in mesenchymal stem cell paracrine-mediated tissue repair. Curr Stem Cell Res Ther. 2016;11:585\u201392.","journal-title":"Curr Stem Cell Res Ther"},{"key":"3347_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3389\/fendo.2019.00585","volume":"10","author":"EM Garc\u00eda-Cuesta","year":"2019","unstructured":"Garc\u00eda-Cuesta EM, Santiago CA, Vallejo-D\u00edaz J, Juarranz Y, Rodr\u00edguez-Frade JM, Mellado M. The role of the CXCL12\/CXCR4\/ACKR3 axis in autoimmune diseases. Front Endocrinol. 2019;10:585.","journal-title":"Front Endocrinol"},{"key":"3347_CR17","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1046\/j.1365-2567.2000.00954.x","volume":"99","author":"T Jinquan","year":"2000","unstructured":"Jinquan T, Quan S, Jacobi HH, Madsen HO, Glue C, Skov PS, et al. CXC chemokine receptor 4 expression and stromal cell-derived factor-1\u03b1-induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin-4 and interleukin-10. Immunology. 2000;99:402\u201310.","journal-title":"Immunology"},{"key":"3347_CR18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1365-2249.2007.03370.x","volume":"148","author":"E Aboumrad","year":"2007","unstructured":"Aboumrad E, Madec AM, Thivolet C. The CXCR4\/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes. Clin Exp Immunol. 2007;148:432\u20139.","journal-title":"Clin Exp Immunol"},{"key":"3347_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s11892-016-0807-6","volume":"16","author":"A Spence","year":"2016","unstructured":"Spence A, Tang Q. Restoring regulatory T cells in type 1 diabetes. Curr Diab Rep. 2016;16:110.","journal-title":"Curr Diab Rep"},{"key":"3347_CR20","doi-asserted-by":"publisher","first-page":"29752","DOI":"10.1074\/jbc.M300489200","volume":"278","author":"CR Yu","year":"2003","unstructured":"Yu CR, Mahdi RM, Ebong S, Vistica BP, Gery I, Egwuagu CE. Suppressor of cytokine signaling 3 regulates proliferation and activation of T-helper cells. J Biol Chem. 2003;278:29752\u20139.","journal-title":"J Biol Chem"},{"key":"3347_CR21","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s00125-008-1090-0","volume":"51","author":"SG R\u00f8nn","year":"2008","unstructured":"R\u00f8nn SG, B\u00f6rjesson A, Bruun C, Heding PE, Frob\u00f8se H, Mandrup-Poulsen T, et al. Suppressor of cytokine signalling-3 expression inhibits cytokine-mediated destruction of primary mouse and rat pancreatic islets and delays allograft rejection. Diabetologia. 2008;51:1873\u201382.","journal-title":"Diabetologia"},{"key":"3347_CR22","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1084\/jem.20012041","volume":"196","author":"SF Soriano","year":"2002","unstructured":"Soriano SF, Hernanz-Falc\u00f3n P, Rodr\u00edguez-Frade JM, De Ana AM, Garz\u00f3n R, Carvalho-Pinto C, et al. Functional inactivation of CXC chemokine receptor 4-mediated responses through SOCS3 up-regulation. J Exp Med. 2002;196:311\u201321.","journal-title":"J Exp Med"},{"key":"3347_CR23","doi-asserted-by":"publisher","first-page":"3775","DOI":"10.2337\/db13-0669","volume":"62","author":"MC Johnson","year":"2013","unstructured":"Johnson MC, Garland AL, Nicolson SC, Li C, Samulski RJ, Wang B, et al. \u03b2-cell-specific IL-2 therapy increases islet Foxp3+Treg and suppresses type 1 diabetes in NOD mice. Diabetes. 2013;62:3775\u201384.","journal-title":"Diabetes"},{"key":"3347_CR24","doi-asserted-by":"publisher","first-page":"5681701","DOI":"10.1155\/2019\/5681701","volume":"2019","author":"Y Liu","year":"2019","unstructured":"Liu Y, Yang Z, Kong D, Zhang Y, Yu W, Zha W. Metformin ameliorates testicular damage in male mice with streptozotocin-induced type 1 diabetes through the PK2\/PKR pathway. Oxid Med Cell Longev. 2019;2019:5681701.","journal-title":"Oxid Med Cell Longev"},{"key":"3347_CR25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jcyt.2012.11.008","volume":"15","author":"CL Rackham","year":"2013","unstructured":"Rackham CL, Dhadda PK, Chagastelles PC, Simpson SJS, Dattani AA, Bowe JE, et al. Pre-culturing islets with mesenchymal stromal cells using a direct contact configuration is beneficial for transplantation outcome in diabetic mice. Cytotherapy. 2013;15:449\u201359.","journal-title":"Cytotherapy"},{"key":"3347_CR26","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.4049\/jimmunol.167.8.4686","volume":"167","author":"P Matthys","year":"2001","unstructured":"Matthys P, Hatse S, Vermeire K, Wuyts A, Bridger G, Henson GW, et al. AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-\u03b3 receptor-deficient mice. J Immunol. 2001;167:4686\u201392.","journal-title":"J Immunol"},{"key":"3347_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2337\/db15-0990","volume":"65","author":"CL Rackham","year":"2016","unstructured":"Rackham CL, Vargas AE, Hawkes RG, Amisten S, Persaud SJ, Austin ALF, et al. Annexin A1 is a key modulator of mesenchymal stromal cell-mediated improvements in islet function. Diabetes. 2016;65:129\u201339.","journal-title":"Diabetes"},{"key":"3347_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.lfs.2015.12.012","volume":"144","author":"D Yan","year":"2016","unstructured":"Yan D, Zhao Y, Gao X, Zhou Y. Acute intravenous glucose load impairs early insulin secretion and insulin content in islet \u03b2 cells in mice. Life Sci. 2016;144:148\u201355.","journal-title":"Life Sci"},{"key":"3347_CR29","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.2337\/db20-0248","volume":"69","author":"JM Barra","year":"2020","unstructured":"Barra JM, Kozlovskaya V, Kharlampieva E, Tse HM. Localized immunosuppression with tannic acid encapsulation delays islet allograft and autoimmune-mediated rejection. Diabetes. 2020;69:1948\u201360.","journal-title":"Diabetes"},{"key":"3347_CR30","doi-asserted-by":"publisher","first-page":"5934","DOI":"10.1074\/jbc.M117.809228","volume":"293","author":"H Inoue","year":"2018","unstructured":"Inoue H, Shirakawa J, Togashi Y, Tajima K, Okuyama T, Kyohara M, et al. Signaling between pancreatic cells and macrophages via S100 calcium-binding protein A8 exacerbates \u03b2-cell apoptosis and islet inflammation. J Biol Chem. 2018;293:5934\u201346.","journal-title":"J Biol Chem"},{"key":"3347_CR31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.autrev.2016.02.017","volume":"15","author":"GJ Kahaly","year":"2016","unstructured":"Kahaly GJ, Hansen MP. Type 1 diabetes associated autoimmunity. Autoimmun Rev. 2016;15:644\u20138.","journal-title":"Autoimmun Rev"},{"key":"3347_CR32","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1210\/er.2018-00154","volume":"40","author":"MR Rickels","year":"2019","unstructured":"Rickels MR, Paul RR. Pancreatic islet transplantation in humans: Recent progress and future directions. Endocr Rev. 2019;40:631\u201368.","journal-title":"Endocr Rev"},{"key":"3347_CR33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/MOT.0000000000000448","volume":"22","author":"CA Chang","year":"2017","unstructured":"Chang CA, Lawrence MC, Naziruddin B. Current issues in allogeneic islet transplantation. Curr Opin Organ Transplant. 2017;22:437\u201343.","journal-title":"Curr Opin Organ Transplant"},{"key":"3347_CR34","doi-asserted-by":"publisher","first-page":"e0116067","DOI":"10.1371\/journal.pone.0116067","volume":"10","author":"L Bao","year":"2015","unstructured":"Bao L, Fu X, Si M, Wang Y, Ma R, Ren X, et al. MicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes. PLoS ONE. 2015;10:e0116067.","journal-title":"PLoS ONE"},{"key":"3347_CR35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.bbamcr.2018.11.013","volume":"1866","author":"S Keshavarz","year":"2019","unstructured":"Keshavarz S, Nassiri SM, Siavashi V, Alimi NS. Regulation of plasticity and biological features of endothelial progenitor cells by MSC-derived SDF-1. Biochim Biophys Acta Mol Cell Res. 2019;1866:296\u2013304.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3347_CR36","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3727\/096368916X690980","volume":"25","author":"G Chen","year":"2016","unstructured":"Chen G, Fang T, Qi Y, Yin X, Di T, Feng G, et al. Combined use of mesenchymal stromal cell sheet transplantation and local injection of SDF-1 for bone repair in a rat nonunion model. Cell Transplant. 2016;25:1801\u201317.","journal-title":"Cell Transplant"},{"key":"3347_CR37","first-page":"35","volume":"11","author":"M Gholami Farashah","year":"2019","unstructured":"Gholami Farashah M, Pasbakhsh P, Omidi A, Nkoonam S, Aryanpour R, Regardi KI. Preconditioning with SDF-1 improves therapeutic outcomes of bone marrow-derived mesenchymal stromal cells in a mouse model of STZ-induced diabetes. Avicenna J Med Biotechnol. 2019;11:35\u201342.","journal-title":"Avicenna J Med Biotechnol"},{"key":"3347_CR38","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1089\/scd.2019.0154","volume":"28","author":"YL Song","year":"2019","unstructured":"Song YL, Jiang H, Jiang NG, Jin YM, Zeng TT. Mesenchymal stem cell-platelet aggregates increased in the peripheral blood of patients with acute myocardial infarction and might depend on the stromal cell-derived factor 1\/CXCR4 axis. Stem Cells Dev. 2019;28:1607\u201319.","journal-title":"Stem Cells Dev"},{"key":"3347_CR39","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/eji.201142071","volume":"42","author":"RL Baker","year":"2012","unstructured":"Baker RL, Mallevaey T, Gapin L, Haskins K. T cells interact with T cells via CD40-CD154 to promote autoimmunity in type 1 diabetes. Eur J Immunol. 2012;42:672\u201380.","journal-title":"Eur J Immunol"},{"key":"3347_CR40","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.2337\/dbi18-0064","volume":"68","author":"S Sharma","year":"2019","unstructured":"Sharma S, Pettus J, Gottschalk M, Abe B, Gottlieb P, Teyton L. Single-cell analysis of CD4 T cells in type 1 diabetes: from mouse to man, how to perform mechanistic studies. Diabetes. 2019;68:1886\u201391.","journal-title":"Diabetes"},{"key":"3347_CR41","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1172\/JCI94549","volume":"127","author":"A Pugliese","year":"2017","unstructured":"Pugliese A. Autoreactive T cells in type 1 diabetes. J Clin Invest. 2017;127:2881\u201391.","journal-title":"J Clin Invest"},{"key":"3347_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3389\/fendo.2017.00343","volume":"8","author":"AL Burrack","year":"2017","unstructured":"Burrack AL, Martinov T, Fife BT. T cell-mediated beta cell destruction: autoimmunity and alloimmunity in the context of type 1 diabetes. Front Endocrinol. 2017;8:343.","journal-title":"Front Endocrinol"},{"key":"3347_CR43","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev.immunol.23.021704.115643","volume":"23","author":"MS Anderson","year":"2005","unstructured":"Anderson MS, Bluestone JA. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol. 2005;23:447\u201385.","journal-title":"Annu Rev Immunol"},{"key":"3347_CR44","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1084\/jem.20052333","volume":"203","author":"I Kinjyo","year":"2006","unstructured":"Kinjyo I, Inoue H, Hamano S, Fukuyama S, Yoshimura T, Koga K, et al. Loss of SOCS3 in T helper cells resulted in reduced immune responses and hyperproduction of interleukin 10 and transforming growth factor-\u03b21. J Exp Med. 2006;203:1021\u201331.","journal-title":"J Exp Med"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03347-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-023-03347-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-023-03347-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T13:08:59Z","timestamp":1688389739000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-023-03347-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3347"],"URL":"https:\/\/doi.org\/10.1186\/s13287-023-03347-y","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"assertion":[{"value":"10 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Tianjin First Central Hospital. All animal experiments were conducted in agreement with the Guide for the Care and Use of Laboratory Animals and were approved by the Committee of Shanghai Tenth People\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}